The University of California system has chosen a new director of its Alzheimer’s Disease Cooperative Study (ADCS), and he says he is already optimistic about the “new era” of research and treatment.
“I think dementia research has entered a new stage,” said University of British Columbia neurologist Howard Feldman, who will formally begin his new role with ADCS in April. “Over the past two decades, we’ve learned an enormous amount about the biology of disease, and have advanced our ability for the first time to visualize the pathology of the dementias in the living brain. This heralds a new era in being able to mark the impact of treatment as we seek the elusive goal of slowing or preventing these dementias.”